First RCT of Lopinavir–Ritonavir on SARS-CoV2

I abhor this sentiment. We need small, theoretically substantive trials capable of advancing medical science rapidly in a mode of strong inference. We do not need large, theoretically shallow trials that grope blindly* for small-effect-size metaphorical ‘oomphs’ that lack realistic theoretical connections to physiology.

  • Cf. #amoEBMism:

https://twitter.com/davidcnorrismd/status/1204744657659297792

3 Likes